Use of Transcranial Magnetic Stimulation (TMS) and Magnetic Resonance Imaging (MRI) to Study Visual Attention

Transcranial Magnetic Stimulation Studies of Visual Attention

The purpose of this study is to learn more about how the brain allows people to focus on important objects and filter out unimportant ones when looking at visual images.

Our senses provide us with a vast amount of information at any given moment in time. For example, visual scenes contain many different objects that cannot be processed simultaneously because of the limited processing capacity of the brain's visual system. Evidence suggests that a a network of brain regions selects relevant information and filters out irrelevant information when people view cluttered visual scenes. This study will use transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (fMRI) to determine how the different brain regions involved in attentional control and filtering interact.

Participants in this study will undergo computer tests, an MRI scan, and TMS. During the MRI, participants will look at pictures and count objects appearing on a screen. During the TMS, participants will perform a computer test. Participants' ability to pay attention will be tested with and without TMS. Participants may be asked to return for additional tests in the future....

Study Overview

Status

Completed

Conditions

Detailed Description

Our senses provide us with a vast amount of information at any given moment in time. For example, visual scenes contain many different objects that cannot all be processed simultaneously because of the limited processing capacity of the visual system. Therefore, attentional mechanisms are required to select relevant objects and filter out irrelevant ones. There is converging evidence from single-cell recording and lesion studies in monkeys and functional brain imaging studies in humans that irrelevant information from cluttered visual scenes is filtered out in extrastriate visual cortex. Functional brain imaging studies also suggest that these attentional filtering mechanisms are mediated by top-down feedback signals arising in higher-order areas in frontal and parietal cortex. However, it is not clear from these studies whether these frontal and parietal brain regions are functionally significant in attentional control of behavior.

Transcranial magnetic stimulation (TMS) applied over a particular cortical region can interfere with cognitive processing in that region, thereby creating a virtual disruption in the intact human cerebral cortex. Hence, this tool can be used to determine if a brain region is functionally involved in the performance of a given cognitive function. In the proposed study, we wish to use TMS to test the hypothesis that attentional filter mechanisms operating in extrastriate cortex are under "top-down" control by regions in the frontal and parietal cortex. Our approach will use a combination of TMS and functional magnetic resonance imaging (fMRI).

First, subjects will participate in an fMRI experiment (93-M-0170) designed to localize the cortical regions of interest (ROIs) that are involved with attentional processing for each subject. Second, TMS will be used to create transient virtual disruptions in frontal and parietal ROIs of normal volunteers while they perform a task requiring spatial attention. We hypothesize that, when TMS is used to interfere with attentional processing, subjects will show impaired performance in a task that requires them to filter out irrelevant visual information. In contrast, performance during TMS should not suffer in a control task in which no irrelevant information needs to be filtered out.

Study Type

Observational

Enrollment

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Bethesda, Maryland, United States, 20892
        • National Institutes of Health Clinical Center, 9000 Rockville Pike

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

  • INCLUSION CRITERIA:

All subjects will be healthy, right-handed volunteers between the ages of 20 and 65.

Subjects must have normal or corrected-to-normal vision.

EXCLUSION CRITERIA

Pregnant women will be excluded.

Subjects with a personal or family history of seizures will be excluded.

Subjects with a history of neurologic disease, ocular foreign body, increased intracranial pressure, open head injury or significant closed head injury will be excluded.

Subjects with cochlear implants, implanted brain stimulators, aneurysm clips or other metal in the head (except mouth) will be excluded.

Subjects taking tricyclic anti-depressants, neuroleptic agents or other drugs that lower the seizure threshold will be excluded.

Subjects with a history of illicit drug use or who are abusing or withdrawing from alcohol abuse will be excluded.

Subjects with a history of a major psychiatric disorder will be excluded.

Subjects with implanted medication pumps, pacemakers, intracardiac lines or significant heart disease will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 14, 2000

Primary Completion (Actual)

April 1, 2002

Study Completion (Actual)

April 1, 2002

Study Registration Dates

First Submitted

September 16, 2000

First Submitted That Met QC Criteria

September 16, 2000

First Posted (Estimate)

September 18, 2000

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 30, 2017

Last Verified

June 8, 2009

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe